Toyokazu Ishikawa

发表

Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

T. Kurata, H. Asanuma, A. Kojima, 2003, Journal of Virology.

HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2011, Anticancer research.

Comparing of Enzyme Linked Immunosolvent Assay, Serum Neutralization and Fluorescent Antibody Method for Measuring the Avian Leukosis Virus Antibody

N. Kunita, K. Takaku, Y. Isshiki, 1991 .

Immunogenicity of influenza vaccine among children

Y. Hirota, S. Shindo, Kazuya Ito, 2022 .

VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia.

H. Asada, H. Iso, K. Yamanishi, 2015, Journal of dermatological science.

Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study

H. Asada, H. Iso, K. Yamanishi, 2015, Journal of epidemiology.

The Shozu Herpes Zoster (SHEZ) Study: Rationale, Design, and Description of a Prospective Cohort Study

H. Asada, H. Iso, K. Yamanishi, 2012, Journal of epidemiology.

Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.

Hidehiro Takahashi, T. Sata, T. Kurata, 2010, Vaccine.

Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.

Hidehiro Takahashi, W. Hall, H. Sawa, 2009, Microbes and infection.

Poly-γ-Glutamic Acid Nanoparticles and Aluminum Adjuvant Used as an Adjuvant with a Single Dose of Japanese Encephalitis Virus-Like Particles Provide Effective Protection from Japanese Encephalitis Virus

M. Akashi, T. Akagi, K. Yamanishi, 2011, Clinical and Vaccine Immunology.

Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.

M. Akashi, T. Akagi, K. Yamanishi, 2008, Vaccine.

Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone.

T. Sata, T. Kurata, A. Kojima, 2004, Vaccine.

Apply of Enzyme Linked Immunosolvent Assay for Avian Leukosis Virus Antibody Detection in Monitoring System of Specific Pathogen Free Chicken

N. Kunita, K. Takaku, Y. Isshiki, 1991 .

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

M. Akashi, T. Akagi, K. Yamanishi, 2007, Vaccine.

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).

Y. Okuno, Y. Gomi, S. Manabe, 2012, Vaccine.

Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column.

Hidehiro Takahashi, T. Sata, T. Kurata, 2011, Journal of virological methods.

Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Anticancer research.

DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.

K. Yamanishi, Michio Suzuki, Y. Gomi, 2008, Vaccine.

Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.

K. Ishii, T. Horii, T. Tougan, 2010, Parasitology international.

The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys

K. Morita, Y. Okuno, S. Manabe, 2015, Virology Journal.

Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine

M. Tashiro, Tadaki Suzuki, T. Sata, 2012, Journal of medical virology.

Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts

T. Kuzuhara, Y. Okuno, Y. Asakawa, 2011, PloS one.

Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.

S. Tamura, T. Tanimoto, I. Fuke, 2005, Vaccine.

Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.

Yasuko Mori, Shigefumi Okamoto, Takeshi Tanimoto, 2008, The Journal of infectious diseases.

Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection

M. Akashi, T. Akagi, K. Yamanishi, 2012, Clinical and Vaccine Immunology.

Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate.

S. Inoue, Guillermo Posadas-Herrera, F. Natividad, 2010, Vaccine.

The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys

K. Morita, Y. Okuno, S. Manabe, 2015, Virology Journal.

Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man

Y. Iba, Y. Kurosawa, T. Yoshikawa, 2011, The Journal of general virology.

Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.

Y. Iba, Y. Kurosawa, T. Yoshikawa, 2010, Virology.

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2017, BMC Cancer.

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma

S. Takada, S. Miyamoto, Fusanori Yotsumoto, 2014, Cancer medicine.

Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.

K. Yamanishi, K. Hayashida, Y. Gomi, 2015, Journal of immunological methods.

Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster

H. Asada, H. Iso, K. Yamanishi, 2012, Epidemiology and Infection.

Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.

Mitsuru Akashi, Yasuko Mori, Shigefumi Okamoto, 2009, Vaccine.

An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.

H. Asada, H. Iso, K. Yamanishi, 2013, Journal of dermatological science.

Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster

H. Asada, H. Iso, Y. Mori, 2012, Epidemiology and Infection.